Donor-specific effects played a large role in engraftment success and potentially GVHD risk in this study. Three patients developed acute GVHD; all received FMT from Donor 1 ... protective antibodies ...

The Fred Hutch trial illustrates this next phase in the development of donor-derived microbial ... be used to improve human ...

Here, the authors profile bacterial engraftment in UC patients receiving FMT from a single donor and placebo samples ... and potential transfer to the human gut.

This donor — a colorectal cancer survivor who had a complete response to immunotherapy — was identified through an ongoing FMT trial at ... specializing in human and planetary health.